Literature DB >> 1696270

Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self-regulating system.

Y Sato1, R Tsuboi, R Lyons, H Moses, D B Rifkin.   

Abstract

The conversion of latent transforming growth factor beta (LTGF-beta) to the active species, transforming growth factor beta (TGF-beta), has been characterized in heterotypic cultures of bovine aortic endothelial (BAE) cells and bovine smooth muscle cells (SMCs). The formation of TGF-beta in co-cultures of BAE cells and SMCs was documented by a specific radioreceptor competition assay, while medium from homotypic cultures of BAE cells or SMCs contained no active TGF-beta as determined by this assay. The concentration of TGF-beta in the conditioned medium of heterotypic co-cultures was estimated to be 400-1,200 pg/ml using the inhibition of BAE cell migration as an assay. Northern blotting of poly A+ RNA extracted from both homotypic and heterotypic cultures of BAE cells and SMCs revealed that BAE cells produced both TGF-beta 1 and TGF-beta 2, while SMCs produced primarily TGF-beta 1. No change in the expression of these two forms of TGF-beta was apparent after 24 h in heterotypic cultures. Time course studies on the appearance of TGF-beta indicated that most of the active TGF-beta was generated within the first 12 h after the establishment of co-cultures. The generation of TGF-beta in co-cultures stimulated the production of the protease inhibitor plasminogen activator inhibitor-1 (PAI-1). The inclusion of neutralizing antibodies to TGF-beta in the co-culture medium blocked the observed increase in PAI-1 levels. The increased expression of PAI-1 subsequent to TGF-beta formation blocked the activation of the protease required for conversion of LTGF-beta to TGF-beta as the inclusion of neutralizing antibodies to PAI-1 in the co-culture medium resulted in prolonged production of TGF-beta. This effect was lost upon removal of the PAI-1 antibodies. Thus, the activation of LTGF-beta appears to be a self-regulating system.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1696270      PMCID: PMC2116212          DOI: 10.1083/jcb.111.2.757

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  38 in total

1.  The murine transforming growth factor-beta precursor.

Authors:  R Derynck; J A Jarrett; E Y Chen; D V Goeddel
Journal:  J Biol Chem       Date:  1986-04-05       Impact factor: 5.157

2.  An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes.

Authors:  A Antonelli-Orlidge; K B Saunders; S R Smith; P A D'Amore
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

3.  Environment-dependent growth inhibition of human epidermal keratinocytes by recombinant human transforming growth factor-beta.

Authors:  B J Rollins; T M O'Connell; G Bennett; L E Burton; C D Stiles; J G Rheinwald
Journal:  J Cell Physiol       Date:  1989-06       Impact factor: 6.384

4.  Transforming growth factor beta alters plasminogen activator activity in human skin fibroblasts.

Authors:  M Laiho; O Saksela; J Keski-Oja
Journal:  Exp Cell Res       Date:  1986-06       Impact factor: 3.905

5.  Recombinant TGF-beta 1 is synthesized as a two-component latent complex that shares some structural features with the native platelet latent TGF-beta 1 complex.

Authors:  L M Wakefield; D M Smith; S Broz; M Jackson; A D Levinson; M B Sporn
Journal:  Growth Factors       Date:  1989       Impact factor: 2.511

6.  Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha.

Authors:  M Sawdey; T J Podor; D J Loskutoff
Journal:  J Biol Chem       Date:  1989-06-25       Impact factor: 5.157

7.  Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-beta 1.

Authors:  J Keski-Oja; R M Lyons; H L Moses
Journal:  Cancer Res       Date:  1987-12-15       Impact factor: 12.701

8.  Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium.

Authors:  R M Lyons; J Keski-Oja; H L Moses
Journal:  J Cell Biol       Date:  1988-05       Impact factor: 10.539

9.  Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta.

Authors:  M Laiho; O Saksela; P A Andreasen; J Keski-Oja
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

10.  Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture.

Authors:  Y Sato; D B Rifkin
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

View more
  101 in total

Review 1.  Latent-TGF-beta: an overview.

Authors:  D A Lawrence
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

Review 2.  The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer.

Authors:  G Cox; W P Steward; K J O'Byrne
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

3.  Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis.

Authors:  Q Yu; I Stamenkovic
Journal:  Genes Dev       Date:  2000-01-15       Impact factor: 11.361

Review 4.  The extracellular regulation of growth factor action.

Authors:  R Flaumenhaft; D B Rifkin
Journal:  Mol Biol Cell       Date:  1992-10       Impact factor: 4.138

Review 5.  Mathematical modeling of tumor-induced angiogenesis.

Authors:  Nikos V Mantzaris; Steve Webb; Hans G Othmer
Journal:  J Math Biol       Date:  2004-02-06       Impact factor: 2.259

Review 6.  Role of reactive oxygen and nitrogen species in the vascular responses to inflammation.

Authors:  Peter R Kvietys; D Neil Granger
Journal:  Free Radic Biol Med       Date:  2011-11-12       Impact factor: 7.376

7.  Brain pericytes: emerging concepts and functional roles in brain homeostasis.

Authors:  Masahiro Kamouchi; Tetsuro Ago; Takanari Kitazono
Journal:  Cell Mol Neurobiol       Date:  2011-03       Impact factor: 5.046

8.  Integrin alpha3beta1 potentiates TGFbeta-mediated induction of MMP-9 in immortalized keratinocytes.

Authors:  John M Lamar; Vandana Iyer; C Michael DiPersio
Journal:  J Invest Dermatol       Date:  2007-08-30       Impact factor: 8.551

9.  VE-statin, an endothelial repressor of smooth muscle cell migration.

Authors:  Fabrice Soncin; Virginie Mattot; Frédéric Lionneton; Nathalie Spruyt; Frédéric Lepretre; Agnès Begue; Dominique Stehelin
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

10.  Hypoxia-induced expression of vascular endothelial growth factor by retinal glial cells promotes in vitro angiogenesis.

Authors:  Y Hata; K Nakagawa; T Ishibashi; H Inomata; H Ueno; K Sueishi
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.